Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001062993-22-000244

Options or other derivatives

  • Director acquired 8,920 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Joseph M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +8,920 8,920 D
Loading xslF345X03/form4.xml…